Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C.

Neurobiol Aging. 2010 Feb;31(2):224-43. doi: 10.1016/j.neurobiolaging.2008.04.002.

PMID:
18479783
3.

Nuclear IRS-1 and cancer.

Reiss K, Del Valle L, Lassak A, Trojanek J.

J Cell Physiol. 2012 Aug;227(8):2992-3000. doi: 10.1002/jcp.24019. Review.

4.

Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.

Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D.

Int J Cancer. 2000 Nov 20;89(6):506-13.

5.

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.

Knowlden JM, Gee JM, Barrow D, Robertson JF, Ellis IO, Nicholson RI, Hutcheson IR.

Breast Cancer Res. 2011 Sep 22;13(5):R93. doi: 10.1186/bcr3018.

6.
7.

Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.

Auclair M, Vigouroux C, Desbois-Mouthon C, Deibener J, Kaminski P, Lascols O, Cherqui G, Capeau J, Caron M.

J Clin Endocrinol Metab. 1999 Sep;84(9):3197-206.

PMID:
10487687
8.

Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.

Becker MA, Ibrahim YH, Oh AS, Fagan DH, Byron SA, Sarver AL, Lee AV, Shaw LM, Fan C, Perou CM, Yee D.

PLoS One. 2016 Mar 18;11(3):e0150564. doi: 10.1371/journal.pone.0150564.

9.
10.

Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.

Singh P, Alex JM, Bast F.

Med Oncol. 2014 Jan;31(1):805. doi: 10.1007/s12032-013-0805-3. Review.

PMID:
24338270
11.
12.
13.
14.
15.

Insulin receptor substrates (IRSs) and breast tumorigenesis.

Chan BT, Lee AV.

J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):415-22. doi: 10.1007/s10911-008-9101-9. Review.

17.

Analysis of insulin receptor substrate signaling dynamics on microstructured surfaces.

Lanzerstorfer P, Yoneyama Y, Hakuno F, Müller U, Höglinger O, Takahashi S, Weghuber J.

FEBS J. 2015 Mar;282(6):987-1005. doi: 10.1111/febs.13213.

18.

Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination.

Trojanek J, Ho T, Del Valle L, Nowicki M, Wang JY, Lassak A, Peruzzi F, Khalili K, Skorski T, Reiss K.

Mol Cell Biol. 2003 Nov;23(21):7510-24.

19.

Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis.

Aleem E, Nehrbass D, Klimek F, Mayer D, Bannasch P.

Toxicol Pathol. 2011 Apr;39(3):524-43. doi: 10.1177/0192623310396905.

PMID:
21411721
20.

Xenopus laevis insulin receptor substrate IRS-1 is important for eye development.

Bugner V, Aurhammer T, Kühl M.

Dev Dyn. 2011 Jul;240(7):1705-15. doi: 10.1002/dvdy.22659.

Items per page

Supplemental Content

Support Center